Oppenheimer holds a meeting with CEO Coffey, CFO Look and CMO Heineman on April 24.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ONCY:
- Oncolytics management to meet with Oppenheimer
- Oncolytics price target lowered to $5.00 from $6.00 at Canaccord
- Oncolytics initiated with an Overweight at Cantor Fitzgerald
- Oncolytics Biotech® Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
- Oncolytics reports Q4 EPS (C$0.14) vs. (C$0.14) last year